Urology News and Research

Latest Urology News and Research

FDA clears ArthroCare's Spartan 5.5 Needled Anchor

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration for its Spartan 5.5 Needled Anchor. Spartan is a preloaded threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair.

15 Feb 2011

Aesthetic and dental surgical procedures show greater than average growth

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, standouts in surgical procedures in terms of growth over the next five years are going to be dental implant, facial injectable, optical coherence tomography (OCT) catheter, spinal nonfusion implant, and percutaneous heart valve procedures in North America.

15 Feb 2011

Studies reveal markers for measuring ability of children with ADHD to control impulsive movements

Two research studies published today in Neurology®, the medical journal of the American Academy of Neurology, found markers for measuring the ability of children with Attention Deficit Hyperactivity Disorder (ADHD) to control impulsive movements, which may reveal insights into the neurobiology of ADHD, inform prognosis and guide treatments.

15 Feb 2011

ArthroCare fourth quarter total revenue increases to $92.6 million

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2010.

14 Feb 2011

Full genetic blueprint of multiple prostate tumors laid bare

For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease. The study, made possible by key advances in whole genome sequencing and analysis, points to several new prostate cancer genes and a critical category of genomic changes as important drivers of prostate cancer growth.

10 Feb 2011

US District Court rules in favor of Watson in generic Mucinex patent infringement suit

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.

10 Feb 2011

Study finds dutasteride not cost-effective in prevention of prostate cancer in men at elevated risk

The popular drug dutasteride may not be a cost-effective way to prevent prostate cancer in men who are at elevated risk of developing the disease, according to findings by a UT Southwestern Medical Center researcher.

9 Feb 2011

MRI Medical announces name change to Xeridiem Medical Devices

MRI Medical Inc. is changing its name to Xeridiem Medical Devices, Inc. as part of its corporate development plan.

9 Feb 2011

Study shows dogs can be trained to detect PCa by smelling urine

In the February 2011 issue of European Urology, Jean-Nicolas Cornu and colleagues reported the evaluation of the efficacy of prostate cancer detection by trained dogs on human urine samples.

8 Feb 2011

Patients with kidney tumours can benefit from nephron-sparing surgery

Patients with kidney tumours larger than four centimetres are much more likely to enjoy good long-term renal function if they undergo nephron-sparing surgery rather than radical nephrectomy, according to a study in the February issue of the urology journal BJUI.

7 Feb 2011

Microsulis' Microwave Endometrial Ablation platform sold to Hologic

Microsulis Medical Limited announced this week that it has exclusively licensed to Hologic Inc all rights to its microwave technology in the gynecology and female urology fields of use.

From Hologic, Inc. 5 Feb 2011

Endo Pharmaceutical partners receive Paragraph IV Certification for generic version of LIDODERM

Endo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, have received a Paragraph IV Certification Notice from Mylan Technologies advising of the filing of an Abbreviated New Drug Application for a generic version of LIDODERM.

31 Jan 2011

Apple Valley Medical Clinic inaugurates new Sleep Center to provide quality care

The Apple Valley Medical Clinic has opened a new Sleep Center, located at 15100 Galaxie Avenue in Apple Valley. The center, under the medical direction of Scott Benson, M.D., a family medicine physician with the Apple Valley Medical Clinic, offers preventive care, diagnosis and treatment of sleep disorders.

28 Jan 2011

Endo and Orion enter oncology R&D collaboration

Endo Pharmaceuticals announced today that it has entered into a collaboration agreement with European-based Orion Corporation for the discovery, development and commercialization of assets in Oncology.

28 Jan 2011

St. Michael's Hospital to build first automated high-throughput zebrafish screening facility in Canada

Zebrafish are the new fruit flies.

27 Jan 2011

ACS NSQIP Pediatric helps hospitals prevent complications

A first of its kind surgical quality improvement program for children has the potential to identify outcomes of children's surgical care that can be targeted for quality improvement efforts to prevent complications and save lives. The results of a study of the American College of Surgeons National Surgical Quality Improvement Program-Pediatric (ACS NSQIP Peds) phase 1 pilot were published in the January issue of the Journal of the American College of Surgeons.

27 Jan 2011

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. provided an update on its Global businesses, including a detailed overview of its commercial operations and pipeline developments within its Global Generics and Global Brands businesses, and an update of achievements within its Global Operations. In conjunction with the meeting, the Company provided its preliminary 2011 financial and long term growth forecasts.

21 Jan 2011

Urology News and Research

Latest Urology News and Research

FDA clears ArthroCare's Spartan 5.5 Needled Anchor

Aesthetic and dental surgical procedures show greater than average growth

Studies reveal markers for measuring ability of children with ADHD to control impulsive movements

ArthroCare fourth quarter total revenue increases to $92.6 million

Full genetic blueprint of multiple prostate tumors laid bare

US District Court rules in favor of Watson in generic Mucinex patent infringement suit

Study finds dutasteride not cost-effective in prevention of prostate cancer in men at elevated risk

MRI Medical announces name change to Xeridiem Medical Devices

Study shows dogs can be trained to detect PCa by smelling urine

Patients with kidney tumours can benefit from nephron-sparing surgery

Microsulis' Microwave Endometrial Ablation platform sold to Hologic

Endo Pharmaceutical partners receive Paragraph IV Certification for generic version of LIDODERM

Apple Valley Medical Clinic inaugurates new Sleep Center to provide quality care

Endo and Orion enter oncology R&D collaboration

St. Michael's Hospital to build first automated high-throughput zebrafish screening facility in Canada

ACS NSQIP Pediatric helps hospitals prevent complications

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

EDAP announces placement of first Sonolith i-sys electroconductive lithotripter in South Africa

Researchers identify PBRM1 gene mutation in one in three patients with common form of renal cancer

Kidney transplant surgeon receives Loyola's Spirit of Martin Luther King Jr. Award

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Urology News and Research

Latest Urology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in